Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Compra segura Produto Original
Synergistic anti-leukemic activity with combination of FLT3 inhibitor quizartinib and MDM2 inhibitor milademetan in FLT3-ITD mutant/p53 wild-type acute myeloid leukemia models
hunger is often greatest during the early titration phase
doi: 10.1126/science.adq0328
Any severe abdominal pain lasting more than a few hours warrants urgent medical assessment
US$ 27.40
US$ 24.25
US$ 23.29
US$ 23.26
US$ 20.62
US$ 23.45
US$ 25.40
US$ 29.49
US$ 21.89
US$ 23.02
